Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “SARS Cov2, Immune Response”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableTemporarily pausedNCT07454395
What this trial is testing

Is Swimming a More Tolerable Form of Movement for Individuals With Myalgic Encephalomyelitis/ Chronic Fatigue Syndrome?

Who this might be right for
ME/CFSLong COVIDPost- COVID-19 Syndrome+5 more
Simon Fraser University 50
Post-approval studies (Phase 4)Study completedNCT04869358
What this trial is testing

Exploring the Immune Response to SARS-CoV-2 COVID-19 Vaccines in Patients With Relapsing Multiple Sclerosis (RMS) Treated With Ofatumumab

Who this might be right for
Relapsing Multiple Sclerosis
Novartis Pharmaceuticals 34
Not applicableStudy completedNCT04410432
What this trial is testing

Immune Response and Risk of Serious Infection to SARS-Cov2

Who this might be right for
SARS Cov2, Immune Response
Centre Hospitalier Universitaire Dijon 39
Not applicableStudy completedNCT04355533
What this trial is testing

Immunity Against SARS-CoV2 in Children and Their Parents / COVID-19

Who this might be right for
COVID-19 Infection
Assistance Publique - Hôpitaux de Paris 1,056
Not applicableWithdrawnNCT04340921
What this trial is testing

The Role of Adaptive Immunity in COVID-19 Associated Myocardial Injury

Who this might be right for
Cardiovascular Disease AcuteCardiomyopathiesCOVID
Barts & The London NHS Trust
Not applicableStudy completedNCT04483622
What this trial is testing

Immunoglobulin G Antibody Immune Response Profile Following Infection With SARS-CoV-2 in COVID-19 Egyptian Patients

Who this might be right for
Covid19
Sohag University 33
Not applicableStudy completedNCT04402827
What this trial is testing

Different Susceptibility to SARS CoV-2 Infection Among Health Care Workers Highly Exposed to COVID-19.

Who this might be right for
Health Care Worker Patient TransmissionReceptor Site AlterationSusceptibility, Disease+1 more
Asociacion para el Estudio de las Enfermedades Infecciosas 140
Large-scale testing (Phase 3)Ended earlyNCT05074433
What this trial is testing

Evaluate Efficacy and Safety of Casirivimab+Imdevimab (Monoclonal Antibodies) for Prevention of COVID-19 in Immunocompromised Adolescents and Adults

Who this might be right for
Immunocompromised
Regeneron Pharmaceuticals 66
Not applicableUnknownNCT04872751
What this trial is testing

Immune Response of Haemodialysis Patients Post Covid-19 Vaccination

Who this might be right for
Immune Response Post Covid 19 Vaccination
Penang Hospital, Malaysia 425
Not applicableStudy completedNCT04937556
What this trial is testing

Evaluation of a Probiotic Supplementation in the Immune Response of Participants With COVID-19 (Coronavirus Disease).

Who this might be right for
Covid19
ProbiSearch SL 41
Post-approval studies (Phase 4)Study completedNCT04952766
What this trial is testing

Study Evaluating SARS-CoV-2 (COVID-19) Humoral Response After BNT162b2 Vaccine in Immunocompromised Adults Compared to Healthy Adults

Who this might be right for
Kidney TransplantMyelomaCancer+6 more
Centre Hospitalier Régional d'Orléans 196
Not applicableStudy completedNCT04794829
What this trial is testing

Natural History of Systemic and Nasal Mucosal Immunity to Influenza and SARS-CoV-2 in Adults After Vaccination

Who this might be right for
InfluenzaCOVID-19
National Institute of Allergy and Infectious Diseases (NIAID) 75
Not applicableStudy completedNCT05313074
What this trial is testing

SARS-CoV-2 Specific Immune Response After COVID-19 Vaccination in Cancer Patients

Who this might be right for
COVID-19Cancer
National Cancer Institute, Thailand 311
Post-approval studies (Phase 4)Active Not RecruitingNCT05060991
What this trial is testing

Impact of Immunosuppression Adjustment on COVID-19 Vaccination Response in Kidney Transplant Recipients

Who this might be right for
COVID-19ImmunosuppressionVaccine Response Impaired
University of California, Davis 14
Not applicableStudy completedNCT06054438
What this trial is testing

Examining the Function of Cs4 on Post-COVID-19 Disorders

Who this might be right for
Long COVID
The University of Hong Kong 110
Testing effectiveness (Phase 2)Study completedNCT05210101
What this trial is testing

A Safety and Tolerability Study of Sotrovimab (VIR-7831) Prophylaxis Against COVID-19 in Immunocompromised Individuals

Who this might be right for
SARS CoV 2 Infection
Sophia Koo, M.D. 93
Not applicableStudy completedNCT05060939
What this trial is testing

SARS-CoV-2 Infection in COVID-19 Vaccinated Patients

Who this might be right for
COVID-19
Hospices Civils de Lyon 1,072
Testing effectiveness (Phase 2)UnknownNCT05133609
What this trial is testing

COVID-19 VACCINE SAFETY AND EFFECTIVENESS

Who this might be right for
SARS-CoV-2 Infection
Federal University of Espirito Santo 550
Not applicableStudy completedNCT05171998
What this trial is testing

Characterisation of the Immune Response to SARS-CoV-2 Infection / COVID-19 in Type 1 Diabetes

Who this might be right for
SARS-CoV2 Infection Common PathogensDiabetes Mellitus, Type 1
Cwm Taf University Health Board (NHS) 30
Not applicableStudy completedNCT05465863
What this trial is testing

Humoral and Cellular İmmune Response to SARS-CoV-2 mRNA BNT162b2 Vaccine in Children With Chronic Kidney Diseases

Who this might be right for
Chronic Kidney Disease 5DChronic Kidney Disease 5T
Istanbul University - Cerrahpasa 101
Next Page